PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Capital Safety Group (Northern Europe) Limited

USPTO PatentsView assignee record - 5 granted patents across 2 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A62B (Devices, Apparatus OR Methods FOR Life-saving).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Capital ranks #45,452 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 2 technology areas.

#45,452
of 49,997 US assignees by volume
8th percentile
by Innovation Score (20.9/100)
16.2
avg claims per patent
-75%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R45452 · Foreign Corporation #45,452 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 5 grants
  • BOTTOM-DECILE #45,452/49,997
  • PHOTO-FINISH Candesant Biomedical
  • CPC-NARROW A62B · 2 areas
  • INNOV-THIN 20.9/100
  • CLAIMS-RICH 16.2 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -75% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Candesant Biomedical, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Capital’s 20.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Capital

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Capital's Innovation Score is 20.9/100 (8th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Capital?

Each dot is one of Capital’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Capital’s own 16.2 claims/patent is at or below the 17.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Capital vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 4.95.05.055.05.05.1 1015202530 Granted patents (volume) Avg claims / patent Candesant Biomedical, Inc. - 5, 26Candesant Biomedi…Cane Creek Cycling Components, Inc. - 5, 20Cane Creek Cyclin…Cangrade, Inc. - 5, 20CangradeCanna-Chemistries LLC - 5, 14.6Canna-chemistriesCapricor, Inc. - 5, 17.6CapricorCaptain JRT LLC - 5, 21.8Captain JRTCaptek Softgel International - 5, 15Captek Softgel In…Carbon Robotics, Inc. - 5, 15.6Carbon RoboticsCapital Safety Group (Northern Europe) Limited - 5, 16.2Capital Safety Gr…
Capital vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Capital's grants concentrate

Capital Safety Group (Northern Europe) Limited is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A62B (Devices, Apparatus OR Methods FOR Life-saving). By volume, Capital sits between Candesant Biomedical, Inc. and Carbon Robotics, Inc..

Who files at Capital's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Capital holds 5 patents at rank #45,735, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Capital

By rank, the assignees closest to #45,735 in granted patent volume.

Leaders in A62B (Devices)

Other assignees with the most granted patents in Capital's primary technology class.

Capital's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

21 8th percentile higher than 8% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

1 20152016201820192020 1
USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Capital Safety Group (Northern Europe) Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 20.0%
2016 1 20.0%
2018 1 20.0%
2019 1 20.0%
2020 1 20.0%

Which technologies does Capital Safety Group (Northern Europe) Limited patent most?

Top 2 of 2 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Capital Safety Group (Northern Europe) Limited's patent record in context - here's where to go next.

  • Capital Safety Group (Northern Europe) Limited's lead technology class is A62B (Devices, Apparatus OR Methods FOR Life-saving), 100% of its portfolio - see every assignee active in that class. Explore A62B
  • Ranked #45,452 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Capital Safety Group (Northern Europe) Limited against Candesant Biomedical, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 20.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.